Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Aug-24 4:26 PM View:  | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Aug-24 | Market Sale | 3,989 | $18.50 | $73,812.50 | (< 1%) 511.57K to 507.58K | (8%) |
| 20-Aug-24 4:26 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Aug-24 | Market Sale | 9,650 | $18.50 | $178,564.00 | (< 1%) 1.13M to 1.12M | (8%) |
| 20-Aug-24 4:26 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Aug-24 | Market Sale | 1,027 | $18.50 | $19,003.60 | (2%) 65.76K to 64.73K | (8%) |
| 20-Aug-24 4:26 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Aug-24 | Market Sale | 1,064 | $18.50 | $19,688.30 | (2%) 52.52K to 51.45K | (8%) |
| 24-Jul-24 4:05 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 22-Jul-24 | Private Sale | 812 | $23.01 | $18,688.20 | (2%) 53.33K to 52.52K | |
| 09-Jul-24 4:05 PM View: | White Mark Andrew See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 08-Jul-24 | Market Sale | 3,026 | $20.40 | $61,715.30 | (4%) 75.25K to 72.22K | 2% |
| 20-May-24 4:29 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 16-May-24 | Option Sale | 1,048 | $23.35 | $24,470.80 | (2%) 66.81K to 65.76K | |
| 20-May-24 4:36 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-May-24 | Private Sale | 1,079 | $23.35 | $25,194.70 | (2%) 54.41K to 53.33K | |
| 20-May-24 4:26 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-May-24 | Option Sale | 4,046 | $23.35 | $94,474.10 | (< 1%) 515.62K to 511.57K | |
| 20-May-24 4:33 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 16-May-24 | Option Sale | 9,790 | $23.35 | $228,596.00 | (< 1%) 1.14M to 1.13M | |
| 20-May-24 4:29 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 14-May-24 | Option Exercise | 2,420 | -- | -- | 13% 18.68K to 21.1K | |
| 20-May-24 4:26 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 14-May-24 | Option Exercise | 9,543 | -- | -- | 2% 402.88K to 412.43K | |
| 20-May-24 4:33 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 14-May-24 | Option Exercise | 17,662 | -- | -- | 2% 1.03M to 1.05M | |
| 20-May-24 4:39 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 02-May-24 | Gift | 113,124 | -- | -- | (39%) 287.62K to 174.5K | |
| 20-May-24 4:39 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 02-May-24 | Gift | 59,716 | -- | -- | (34%) 174.5K to 114.78K | |
| 24-Apr-24 4:06 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 22-Apr-24 | Private Sale | 833 | $22.87 | $19,050.70 | (2%) 55.24K to 54.41K | |
| 16-Apr-24 5:45 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 15-Apr-24 | Option Exercise | 29,624 | $4.34 | $128,627.00 | 31% 95.16K to 124.78K | |
| 16-Apr-24 5:45 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 15-Apr-24 | Option Sale | 10,000 | $24.05 | $240,520.00 | (8%) 124.78K to 114.78K | |
| 16-Apr-24 5:45 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 12-Apr-24 | Option Sale | 70,000 | $24.36 | $1,705,260.00 | (42%) 165.16K to 95.16K | |
| 16-Apr-24 5:45 PM View: | Southwell David P Director | Rocket Pharmaceuticals, Inc. (RCKT) | 12-Apr-24 | Option Exercise | 70,000 | $4.34 | $303,940.00 | 74% 95.16K to 165.16K | |
| 10-Apr-24 8:39 PM View: | White Mark Andrew See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 08-Apr-24 | Private Sale | 12,532 | $24.64 | $308,763.00 | (14%) 87.76K to 75.23K | |
| 03-Apr-24 6:02 PM View: | Ondrey Aaron Chief Financial Officer | Rocket Pharmaceuticals, Inc. (RCKT) | 01-Apr-24 | Grant | 46,781 | -- | -- | 100% 0 to 46.78K | |
| 25-Mar-24 8:54 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 21-Mar-24 | Sale | 2,490 | $28.10 | $69,979.00 | (4%) 57.73K to 55.24K | |
| 25-Mar-24 8:58 PM View: | Makker Gotham Director | Rocket Pharmaceuticals, Inc. (RCKT) | 21-Mar-24 | Private Sale | 274,000 | $28.43 | $7,790,940.00 | (43%) 639.91K to 365.91K | |
| 04-Mar-24 6:54 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 29-Feb-24 | Option Exercise | 10,000 | $12.55 | $125,500.00 | 46% 21.52K to 31.52K | |
| 04-Mar-24 6:48 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 29-Feb-24 | Private Sale | 4,100 | $29.33 | $120,257.00 | (18%) 22.78K to 18.68K | |
| 04-Mar-24 6:54 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 29-Feb-24 | Option Sale | 10,000 | $29.84 | $298,450.00 | (32%) 31.52K to 21.52K | |
| 21-Feb-24 8:54 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Grant | 8,322 | -- | -- | 51% 16.43K to 24.75K | |
| 21-Feb-24 8:54 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Sale | 3,576 | $29.84 | $106,701.00 | (14%) 26.36K to 22.78K | |
| 21-Feb-24 8:54 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Sale | 3,238 | $29.84 | $96,615.40 | (13%) 24.75K to 21.52K | |
| 21-Feb-24 8:54 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Grant | 33,288 | -- | -- | 9% 352.75K to 386.04K | |
| 21-Feb-24 8:54 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Sale | 7,132 | $29.84 | $212,805.00 | (2%) 386.04K to 378.9K | |
| 21-Feb-24 8:54 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Sale | 20,272 | $29.84 | $604,876.00 | (2%) 1.05M to 1.03M | |
| 21-Feb-24 8:54 PM View: | White Mark Andrew Chief Medical Officer | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Grant | 11,096 | -- | -- | 14% 76.66K to 87.76K | |
| 21-Feb-24 8:54 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Grant | 16,644 | -- | -- | 171% 9.71K to 26.36K | |
| 21-Feb-24 8:54 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 16-Feb-24 | Grant | 66,577 | -- | -- | 7% 981.27K to 1.05M | |
| 16-Feb-24 4:05 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Feb-24 | Option Exercise | 6,274 | -- | -- | 62% 10.16K to 16.43K | |
| 16-Feb-24 4:05 PM View: | Wilson Martin General Counsel | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Feb-24 | Option Exercise | 9,712 | -- | -- | (50%) 19.42K to 9.71K | |
| 16-Feb-24 4:05 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Feb-24 | Option Exercise | 26,189 | -- | -- | 8% 326.56K to 352.75K | |
| 16-Feb-24 4:05 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Feb-24 | Option Exercise | 46,828 | -- | -- | (5%) 1.03M to 981.27K | |
| 23-Jan-24 4:22 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 22-Jan-24 | Private Sale | 638 | $27.20 | $17,355.50 | (6%) 10.8K to 10.16K | |
| 22-Jan-24 4:05 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 18-Jan-24 | Option Exercise | 1,586 | -- | -- | 17% 9.21K to 10.8K | |
| 16-Nov-23 7:24 PM View: | Makker Gotham Director | Rocket Pharmaceuticals, Inc. (RCKT) | 15-Nov-23 | Private Sale | 20,000 | $22.53 | $450,646.00 | (2%) 1.32M to 1.3M | |
| 16-Nov-23 7:17 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Nov-23 | Option Exercise | 3,989 | -- | -- | 1% 323.72K to 327.71K | |
| 16-Nov-23 7:09 PM View: | Shah Gaurav CEO Director | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Nov-23 | Option Exercise | 7,979 | -- | -- | (< 1%) 947.05K to 939.07K | |
| 16-Nov-23 6:58 PM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 14-Nov-23 | Option Exercise | 725 | -- | -- | 8% 8.76K to 9.48K | |
| 25-Oct-23 9:38 AM View: | Militello John See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 20-Oct-23 | Sale | 564 | $17.06 | $9,622.97 | (6%) 9.32K to 8.76K | |
| 10-Oct-23 4:11 PM View: | Patel Kinnari See Remarks | Rocket Pharmaceuticals, Inc. (RCKT) | 05-Oct-23 | Option Exercise | 3,333 | -- | -- | 1% 320.38K to 323.72K | |
| 30-Aug-23 4:15 PM View: | Rtw Investments, Lp Director 10% Owner | Rocket Pharmaceuticals, Inc. (RCKT) | 28-Aug-23 | Disposition (other) | 1,000,000 | $18.96 | $18,960,000.00 | (3%) 37.82M to 36.82M | (6%) |
| 30-Aug-23 4:15 PM View: | Rtw Investments, Lp Director 10% Owner | Rocket Pharmaceuticals, Inc. (RCKT) | 28-Aug-23 | Acquisition (other) | 1,000,000 | $18.96 | $18,960,000.00 | 3% 36.82M to 37.82M | 6% |
